Glucagon secretion is regulated by circulating
glucose, but it has turned out that
amino acids also play an important role and that hepatic
amino acid metabolism and
glucagon are linked in a mutual feedback cycle, the liver-α-cell axis. On the basis of this knowledge, we hypothesized that hepatic steatosis might impair
glucagon's action on hepatic
amino acid metabolism and lead to hyperaminoacidemia and hyperglucagonemia. We subjected 15 healthy lean and 15 obese steatotic male participants to a pancreatic clamp with
somatostatin and evaluated hepatic
glucose and
amino acid metabolism when
glucagon was at basal levels and at high physiological levels. The degree of steatosis was evaluated from liver biopsy specimens. Total
RNA sequencing of liver biopsy specimens from the obese steatotic individuals revealed perturbations in the expression of genes predominantly involved in
amino acid metabolism. This group was characterized by fasting hyperglucagonemia, hyperaminoacidemia, and no lowering of
amino acid levels in response to high levels of
glucagon. Endogenous
glucose production was similar between lean and obese individuals. Our results suggest that hepatic steatosis causes resistance to the effect of
glucagon on
amino acid metabolism. This results in increased
amino acid concentrations and increased
glucagon secretion, providing a likely explanation for
fatty liver-associated hyperglucagonemia.